USP25 and chronic myelogenous leukemia, BCR-ABL1 positive: Shibata and colleagues have demonstrated that USP25 could decrease CML cell’s senitivity to TKIs via stabilizing BCR-ABL protein in cells carrying the Philadelphia chromosome (Ph) [35].